Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
Jan Krönke(Universitätsmedizin Greifswald), Konstanze Döhner(University Hospital Ulm), Marie von Lilienfeld‐Toal(St James's University Hospital), Mohammed Wattad(San Antonio College), Kai‐Ole Jensen(Johannes Gutenberg University Mainz), Marianne Habdank(Johannes Gutenberg University Mainz), Helmut R. Salih(German Cancer Research Center), Florian Tschürtz(Johannes Gutenberg University Mainz), Daniela Späth(University Hospital Ulm), Brigitte Schlegelberger(Heidelberg University), Michael Lübbert(University of Freiburg), Karina Eiwen(Johannes Gutenberg University Mainz), Richard F. Schlenk(German Cancer Research Center), David Nachbaur(Innsbruck Medical University), Shiva Onken(Johannes Gutenberg University Mainz), Gudrun Göhring(Medizinische Hochschule Hannover), Peter Paschka(European Bioinformatics Institute), Verena I. Gaidzik(European Bioinformatics Institute), Hartmut Döhner(University Hospital Ulm), Detlef Haase(Universitätsmedizin Göttingen), Andrea Corbacioglu(Düsseldorf University Hospital), H.‐G. Mergenthaler(Johannes Gutenberg University Mainz), Gerhard Held(Saarland University), Jürgen Krauter(Klinikum Braunschweig), Thomas Kindler(German Cancer Research Center), Ulrich Germing(Heinrich Heine University Düsseldorf), Arnold Ganser(Medizinische Hochschule Hannover)
Cited by 393
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k